Biomatter Raises $18 Million for AI Enzyme Design
Nov 12, 2026
Funding
ChemT Biotechnology Raises $4 Million Seed Round for AI in Biomanufacturing
Jun 23, 2026
ChemT Biotechnology has raised $4 million in seed funding led by Wavemaker Ventures, with participation from SEEDS and other investors, to expand its AI and experimental infrastructure for biomanufacturing.
ChemT Biotechnology has raised 4 million dollars in a seed round led by Wavemaker Ventures, with participation from co-investment partner SEEDS, an arm of SG Growth Capital. The round also included investors such as Wavemaker 360 Health, Draper University Ventures, and Temasek Life Sciences Accelerator, announced in a press release.
The funding will support ChemT's expansion of its AI and experimental infrastructure aimed at improving the manufacturing and scalability of advanced medicines. The company is developing an intelligence layer within biomanufacturing processes to help organizations better understand cellular behavior during production.
At the center of ChemT's technology is CelMo, a Virtual Cell platform that uses AI to simulate how cells respond to manufacturing conditions, genetic modifications, and other stresses. Its flagship small molecule product, Chemplify, applies the same methodology to T-cell manufacturing, showing improvements in development speed, scalability, and cost efficiency. The new funding will advance CelMo's development and extend its use to additional cellular systems.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly, AI Funding Brief or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareMore from Funding
Nov 13 Peter Sarlin's PostScriptum takes majority stake in Finnish AI deployment firm Brillian Nov 13 MISTT raises £5 million to build a space-and-time data layer for AI and autonomous systems Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 12 Inveniam acquires Docugami, the document AI startup of XML pioneer Jean Paoli Nov 12 Huang's exit puts extra pressure on Anthropic's IPO next week, investors tell FortuneFree newsletter
Industrial AI Weekly
The latest advancements in smart manufacturing, predictive maintenance, AI-driven quality control, supply chain & more.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Atlas Bio raises $12.5 million for virtual drug trials
Oct 27, 2026
Healthcare
Warp Sciences Raises $215 Million to Automate Drug Discovery Labs
Oct 22, 2026
Funding
BioMap Announces 11 AI Life Science Collaborations
Nov 12, 2026
Life Sciences
Araceli Biosciences Adds Investor to $4.5 Million Round
Nov 12, 2026
Funding
Munich's SPARETECH raises $20 million Series B to cut factories' spare-parts inventory with AI
Nov 10, 2026
Funding
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.